Pathogens · 2022 · 17 citations · 30 references
Veterinary MedicineImmunologyNephrologyImmunizationKidney TransplantationVaccinologyImmune Response To VaccinationImmunosuppression In Kidney TransplantationMrna Vaccine TechnologyVaccinationVaccine EffectivenessVaccine EfficacyB Cell Response To VaccinationInfection Risk Under ImmunosuppressionSars-cov-2 InfectionTransplant VaccinationVaccination In Transplant RecipientsVaccination Responses After TransplantVaccine-induced Antibody ResponsesViral Immune Responses
Hemodialysis patients (HDP) and kidney transplant recipients (KTR) have a high risk of infection with SARS-CoV-2 with poor clinical outcomes. Because of this, vaccination of these groups of patients against SARS-CoV-2 is particularly important. However, immune responses may be impaired in immunosuppressed and chronically ill patients. Here, our aim was to compare the efficacy of an mRNA-based vaccine in HDP, KTR, and healthy subjects. DESIGN: In this prospective observational cohort study, the humoral and cellular response of prevalent 192 HDP, 50 KTR, and 28 healthy controls (HC) was assessed 1, 2, and 6 months after the first immunization with the BNT162b2 mRNA vaccine. RESULTS: ≤ 0.05). A SARS-CoV-2 antigen-specific cell response to vaccination was found in 68.8% of HDP, 64.5% of KTR, and 90% of HC. CONCLUSION: The humoral response rates to mRNA-based vaccination of HDPs are comparable to HCs, but antibody titers are lower. Furthermore, HDPs have weaker T-cell response to vaccination than HCs. KTRs have very low humoral and antigen-specific cellular response rates and antibody titers, which requires other vaccination strategies in addition to booster vaccination.
30
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth Williamson, Alex J Walker, Krishnan Bhaskaran et al. · Nature · 2020 · 6.7K citations · Full text
Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +6